Trebananib Completed Phase 2 Trials for Malignancies / Carcinoma NOS / Metastases / Metastatic Colorectal Cancers / Malignant Neoplasm of Colon / Colorectal Cancers / Rectal Carcinoma / Metastatic Cancers / Gastrointestinal Cancers / Oncology Treatment

CompletedTreatment2 IdentifierTitleDrugs
NCT00752570A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma
NCT00583674Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma